Upgrade your HILIC Application to UHPLC

Columns

Upgrade your HILIC Application to UHPLC

14 May, 2015

Published over 11 years ago. See the latest and most current information on Columns.

TSKgel Amide-80, renowned for analysing protein glycosylation, is now available in 2 µm particles, ideally suited for high resolution UHPLC.

TSKgel Amide-80 columns packed with 2 µm silica based particles are the latest additions to the well-known TSKgel Amide-80 series from Tosoh Bioscience.  The amide stationary phase provides a unique selectivity under regular normal phase conditions or in the hydrophilic interaction (HILIC) mode of chromatography.  The Amide-80 phase shows higher retention of polar compounds than other Amide columns on the market.

For years, TSKgel Amide-80 columns have been used successfully for HILIC separations of polar compounds such as saccharides, glycans, oligosaccharides or peptides, documented in more than 250 scientific publications. In parallel to the growth of the biotherapeutics market the use of Amide-phases for glycosylation analysis steadily increased.

Packed with spherical silica particles that are covalently bonded with non-ionic carbamoyl groups, TSKgel Amide-80 provides higher stability than conventional amino-phases and a unique selectivity. The characterisation of the new 2 µm version of TSKgel Amide-80 compared to the renowned 3 µm Amide-80 based on the system proposed by Y. Kawachi et al. (J. Chromatogr. A, 1218 (2011) 5903 ff) proves the similarity in selectivity.

Latest News

ILM 51.5 July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Throwable sensor offers rapid remote detection of chemical threats
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
Tunable infrared chip could sharpen gas leak and pollution detection
Explore more Arrow
Chromatography Today
SLAS Technology Volume 38 highlights AI-driven laboratory automation, transcriptomics and gene therapy
Explore more Arrow